Shanghai Henlius Biotech, Inc. (2696.HK) HKSE
66.70
-0.95(-1.40%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
66.70
-0.95(-1.40%)
Currency In HKD
| Market Cap | 12.1B |
| Enterprise Value | 14.97B |
| P/E Ratio | 38.73 |
| PEG Ratio | 0.39 |
| Price/Sales Ratio | 5.51 |
| Price/Book Ratio | 9.37 |
| Enterprise/Revenue | 5.99 |
| Enterprise/EBITDA | 30.57 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | 0.14 |
| Operating Margin | 0.15 |
| Return On Assets | 0.07 |
| Return On Equity | 0.26 |
| Revenue | 5.72B |
| Revenue/Share | 10.67 |
| Gross Profit | 4.18B |
| EBITDA | 1.15B |
| Net Income | 820.47M |
| Diluted EPS | 1.51 |
| Total Cash | 972.5M |
| Total Cash/Share | 1.79 |
| Total Debt | 3.67B |
| Total Debt/Equity | 1.08 |
| Current Ratio | 0.68 |
| Book Value Per Share | 6.27 |
| 52-Week Change | 115.51 |
| 52-Week High | 92 |
| 52-Week Low | 23 |
| Moving Average 50 Days | 65.36 |
| Moving Average 200 Days | 66.23 |
| Average Volume | 945,021 |
| Shares Outstanding | 543.48M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |